Huge improvements in prevention, diagnosis and treatment have driven the fall, Cancer Research UK says ...

SAN ANTONIO, March 10, 2026--bioAffinity Technologies launches 2,000-patient longitudinal study for its CyPath Lung noninvasive diagnostic for lung cancer.

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...

As the UK National Screening Committee (UK NSC) reviews chronic obstructive pulmonary disease (COPD) screening, there is an opportunity to move ...

Recognising these subtle body changes can lead to an earlier diagnosis, when treatment is more likely to be successful ...

Cancer patients are due to benefit from a new surgical robot in Sheffield after a funding boost. Sheffield Hospitals Charity ...

Her German shepherd saved her life by detecting cancer in its earliest stage–and now an E-nose can detect tumors with AI chemical training.

Jiahui International Cancer Center (JICC) has stabilized a U.S. patient with advanced non‑small cell lung cancer (NSCLC) and ...

March is Ovarian Cancer Awareness Month - but one local survivor has called for greater understanding of the condition which ...

London, UK. 10 March 2026. BeOne Medicines (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the Health Service Executive (HSE) in the Republic of Ireland has ...

Scientists have reported results from an early-stage trial of an immunotherapy drug called VIR-5500. The drug offers new hope for men with advanced prostate cancer who have stopped responding to other ...

The "Checkpoint Inhibitor Refractory Cancer Drugs Market – Growth, Share, Opportunities & Competitive Analysis, 2025 – 2032" report has been added to the Credence Research Inc. offering.